@article{ART003128441,
author={Yixuan Zhu and Xiaoyan Ma and Wenjing Ni and Yee Hui Yeo and Junping Shi and Jie Li},
title={Metabolic-associated fatty liver disease is less effective in predicting mortality than non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease: Letter to the editor on “Prognosis of biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: A sub-analysis of the CLIONE study”},
journal={Clinical and Molecular Hepatology},
issn={2287-2728},
year={2024},
volume={30},
number={4},
pages={974-977}
}

TY - JOUR
AU - Yixuan Zhu
AU - Xiaoyan Ma
AU - Wenjing Ni
AU - Yee Hui Yeo
AU - Junping Shi
AU - Jie Li
TI - Metabolic-associated fatty liver disease is less effective in predicting mortality than non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease: Letter to the editor on “Prognosis of biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: A sub-analysis of the CLIONE study”
T2 - Clinical and Molecular Hepatology
JO - Clinical and Molecular Hepatology
PY - 2024
VL - 30
IS - 4
PB - 대한간학회
SP - 974
EP - 977
SN - 2287-2728
AB -
KW - Fatty liver, NAFLD, Mortality, Predictive value of tests
DO -
UR -
ER -

Yixuan Zhu, Xiaoyan Ma, Wenjing Ni, Yee Hui Yeo, Junping Shi and Jie Li. 2024, "Metabolic-associated fatty liver disease is less effective in predicting mortality than non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease: Letter to the editor on “Prognosis of biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: A sub-analysis of the CLIONE study”", Clinical and Molecular Hepatology, vol.30, no.4 pp.974-977.

Yixuan Zhu, Xiaoyan Ma, Wenjing Ni, Yee Hui Yeo, Junping Shi, Jie Li "Metabolic-associated fatty liver disease is less effective in predicting mortality than non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease: Letter to the editor on “Prognosis of biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: A sub-analysis of the CLIONE study”" Clinical and Molecular Hepatology 30.4 pp.974-977 (2024) : 974.

Yixuan Zhu, Xiaoyan Ma, Wenjing Ni, Yee Hui Yeo, Junping Shi, Jie Li. Metabolic-associated fatty liver disease is less effective in predicting mortality than non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease: Letter to the editor on “Prognosis of biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: A sub-analysis of the CLIONE study”. 2024; 30(4), 974-977.

Yixuan Zhu, Xiaoyan Ma, Wenjing Ni, Yee Hui Yeo, Junping Shi and Jie Li. "Metabolic-associated fatty liver disease is less effective in predicting mortality than non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease: Letter to the editor on “Prognosis of biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: A sub-analysis of the CLIONE study”" Clinical and Molecular Hepatology 30, no.4 (2024) : 974-977.

Yixuan Zhu; Xiaoyan Ma; Wenjing Ni; Yee Hui Yeo; Junping Shi; Jie Li. Metabolic-associated fatty liver disease is less effective in predicting mortality than non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease: Letter to the editor on “Prognosis of biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: A sub-analysis of the CLIONE study”. Clinical and Molecular Hepatology, 30(4), 974-977.

Yixuan Zhu; Xiaoyan Ma; Wenjing Ni; Yee Hui Yeo; Junping Shi; Jie Li. Metabolic-associated fatty liver disease is less effective in predicting mortality than non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease: Letter to the editor on “Prognosis of biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: A sub-analysis of the CLIONE study”. Clinical and Molecular Hepatology. 2024; 30(4) 974-977.

Yixuan Zhu, Xiaoyan Ma, Wenjing Ni, Yee Hui Yeo, Junping Shi, Jie Li. Metabolic-associated fatty liver disease is less effective in predicting mortality than non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease: Letter to the editor on “Prognosis of biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: A sub-analysis of the CLIONE study”. 2024; 30(4), 974-977.

Yixuan Zhu, Xiaoyan Ma, Wenjing Ni, Yee Hui Yeo, Junping Shi and Jie Li. "Metabolic-associated fatty liver disease is less effective in predicting mortality than non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease: Letter to the editor on “Prognosis of biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: A sub-analysis of the CLIONE study”" Clinical and Molecular Hepatology 30, no.4 (2024) : 974-977.